Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
First Antibiotic?
First true antibiotic? |
"antimetabolite" sulfonamide by Domagk in 1934
Penicillin, Fleming 1928 |
|
Describe the relationship between early Sulfonamide and PAB
PAB and Folic Acid? |
PAB was structurally similar and when administered competitively inhibited Sulfonamide
Non-competitively, if adequate folic acid was available drug would have no effect |
|
Why do sulfonamides work?
|
Humans require presynthesized folic acid while Bacteria must make their own and cannot absorb Folic Acid itself. Therefore inhibition of the synthesis only targets bacterias
|
|
Limitations of drug efficacy?
|
speed of work, sensitivity of microbe, side effects of host
|
|
-Cidal vs -Static
|
cidals better when bodies defenses are low
static give time for body to get rid of organisms two definitions not absolute |
|
What is Trimethoprim's mechanism of action?
Why isn't this dangerous for humans? |
Halts the function of folic acid by inhibiting dihydrofolate reductase, preventing conversion to tetrahydrofolate
The amount needed for 50% inhibition of bacteria is extremely lower than in mammals |
|
Why is tetracycline not damaging to humans?
|
Despite requiring the same dose for efficacy, bacteria concentrate it in their cells while mammals do not
|
|
Penicillins/Cephalosporins
Resistance Mechanism |
Hydrolysis of B-lactam ring by B-lactamase
|
|
Methicillin
Resistance Mechanism |
Change in Penicillin-Binding Protein (PBP)
|
|
Tetracyclines
Resistance Mechanism |
Efflux pump pushes drug out of cell
|
|
First Antibiotic?
First true antibiotic? |
"antimetabolite" sulfonamide by Domagk in 1934
Penicillin, Fleming 1928 |
|
Describe the relationship between early Sulfonamide and PAB
PAB and Folic Acid? |
PAB was structurally similar and when administered competitively inhibited Sulfonamide
Non-competitively, if adequate folic acid was available drug would have no effect |
|
Why do sulfonamides work?
|
Humans require presynthesized folic acid while Bacteria must make their own and cannot absorb Folic Acid itself. Therefore inhibition of the synthesis only targets bacterias
|
|
Limitations of drug efficacy?
|
speed of work, sensitivity of microbe, side effects of host
|
|
-Cidal vs -Static
|
cidals better when bodies defenses are low
static give time for body to get rid of organisms two definitions not absolute |
|
What is Trimethoprim's mechanism of action?
Why isn't this dangerous for humans? |
Halts the function of folic acid by inhibiting dihydrofolate reductase, preventing conversion to tetrahydrofolate
The amount needed for 50% inhibition of bacteria is extremely lower than in mammals |
|
Why is tetracycline not damaging to humans?
|
Despite requiring the same dose for efficacy, bacteria concentrate it in their cells while mammals do not
|
|
Penicillins/Cephalosporins
Resistance Mechanism |
Hydrolysis of B-lactam ring by B-lactamase
|
|
Methicillin
Resistance Mechanism |
Change in Penicillin-Binding Protein (PBP)
|
|
Tetracyclines
Resistance Mechanism |
Efflux pump pushes drug out of cell
|
|
Penicillins/Cephalosporins
Resistance Mechanism |
Hydrolysis of b-lactam ring by b-lactamase
|
|
Methicillin
Resistance Mechanism |
change in PBP
|
|
Tetracyclines
|
Efflux pump pushes out of cell
|
|
Aminoglycosides (gentamicin, tobramycin, streptomycin)
|
enzymatic modification by Rplasmid, reduces ribosome affinity and decreases xport into cell
|
|
Sulfonamides
|
sulf resistant dihydropteroate synthase
|
|
Trimethoprim
Resistance Mechanism |
" resistant dihydrofolate reductase
|
|
Erythromycin
Resistance Mechanism |
Methylation of 23S rRNA
|
|
Chloramphenicol
|
Acetylation of OH groups, interference of cell transport
|
|
Oxazolidinones - Linezolid
|
23S rRNA mutation
|
|
Quinolones (ciprofloxacin)
|
mutation of genes for DNAgyrase(G+) + topoisomeraseIV(G-)
|
|
Vancomycin
|
Change in binding site in peptidoglycan target (daladala to daladlac)
|
|
How do B-lactams become broad spectrum
|
They are able to target gram(-)s by modification of the lactam ring
|
|
Modification of second generation B-lactams? Third?
|
2nd - Gram(-)
3rd - CNS entry |
|
Difference between B-lactamases of Gram(+) and Gram(-)?
|
Gram(+)s release a drug-dose dependent amount into the medium, cannot be overcome by high doses
Gram(-)s produce a set amount and retain it in their periplasm, can be overcome with high doses |
|
Non-B-lactamase defenses (+/-)
ex of seriousness |
+s have modified the PBP
-s have mutations in their porins PRSP and MRSA |
|
Biggest risk in ABs currently?
|
Superstrain of S.Aureus which has gained the vancomycin resistance from enterococci
MRSA + VRE --> VRSA |
|
Secondary mechanism of resistance to Fluoroquinolones? (not gyrase/topo mutation)
|
Efflux pump development in gram(+) S.aureus and gram(-)P.Aeruginosa
|
|
Toxicity of Tetracycline?
|
Chelation of Magnesium with bone/teeth malformation in children
|
|
Aminoglycosides
1 - Mechanism (3 step vers) 2 - Two forms of resistance + microbes |
1 - (A) traverse of Gram(-) Outer membrane
(B) Entrance/Use of bi-directly active transport system into cell (C)Binding to 30S ribosome and stopping of transcription at initiation step Resistance 1 is inactivation of transport by Obligate Anaerobics Resistance 2 is by acetyl/phosphoryl/adenyl-ation of Aminoglycosies, inactivating them |
|
What is special about the macrolide Telithromycin?
|
It binds to two places on the 23S ribosome, avoiding the effects of the methylation.
It also is not effected by the efflux pumps |
|
Macrolide resistance?
|
By methylation of the 23S ribosome within the 50S by methylase
methylase activity low until macrolides administered |
|
Linezolid Resistance? (Why is Linezolid special)
|
Resistance is formed by mutation of the 23S ribosome
being completely synthetic, linezolid avoids all preexisting resistance strategies |
|
Antifungal agents + Mechanism
1 - Polyenes 2 - Imidazoles 3 - echinocandins |
1 - Polyenes attack ergosterol rather than cholesterol. Is toxic to RBCs and Kidney
2 - imidazoles attack cytochrome P450 demethylase 3 - echinocandins - target is B-Glucan, not present in human cells |
|
Synergism? Example
|
Greater effect seen with combo
penicillin + gentamicin on enterococci normally gentamicin cannot enter cells, penicillin allows entry of gentamicin |
|
Antagonism? Example
|
One drug negates the other
Penicillin + Tetracycline Tetracycline stops the growth which is essential for the -cidal effects of penicillin, results in only bacteriostatic fx |